Adam Carpenter M.D.
Chief Medical Officer
Dr. Adam Carpenter, MD, a board-certified neurologist, is involved in patient-based research using non-invasive neuroimaging methods to study the function and pathogenesis of several brain disorders. Dr. Carpenter has helped conduct over 15 clinical trials, ranging from local investigator-initiated studies to multinational industry-sponsored trials. Several of these studies have led to new approved treatments for MS. At MarPam Pharma, Dr. Carpenter applies his clinical experience in assuring excellent patient care in the design and conduct of clinical trials for novel therapies.